You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TEVA Sale Disclosure
Shields Matthew · SEC Form 4 · Filed Jun 4, 2026
Sale
Calculated transaction value
$532.33K
Shields Matthew EVP, Global Operations
TEVA
Transaction date
Jun 3, 2026
Public filing date
Jun 4, 2026
Filing lag
Filed 1 day later
TEVA daily price context
Close on/before transaction
$32.83
Jun 3, 2026
First close after public filing
$34.19
Jun 5, 2026
30-day return after filing
+3.22%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 16,195 shares @ $32.87
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-257344
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$532.33K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Jun 3, 2026 | Not reported |
| Teva Pharmaceutical Industries Ltd TEVA Current | Sale | Jun 3, 2026 | $532.33K |
| Teva Pharmaceutical Industries Ltd TEVA | Exercise | Jun 3, 2026 | $0 |